News
20h
Generated $166.8 million in 1Q 2025 revenues, including $149.9 million in U.S. net product salesSYFOVRE® (pegcetacoplan injection) injection demand grew 4% quarter-over-quarter, with U.S. net product ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback